News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
23,933 Results
Type
Article (1190)
Company Profile (3)
Press Release (22740)
Section
Business (11416)
Career Advice (62)
Deals (1489)
Drug Delivery (1)
Drug Development (2160)
Employer Resources (1)
FDA (400)
Job Trends (524)
News (14815)
Policy (714)
Tag
Academia (29)
Allergies (8)
Alliances (797)
ALS (2)
Alzheimer's disease (62)
Antibody-drug conjugate (ADC) (6)
Approvals (427)
Artificial intelligence (7)
Autoimmune disease (14)
Bankruptcy (3)
Best Places to Work (455)
Biosimilars (4)
Biotechnology (1)
Bladder cancer (6)
Breast cancer (29)
Cancer (155)
Cardiovascular disease (16)
Career advice (51)
CAR-T (6)
Cell therapy (9)
Cervical cancer (1)
Clinical research (2062)
Collaboration (22)
Compensation (29)
Complete response letters (1)
COVID-19 (44)
CRISPR (2)
C-suite (8)
Cystic fibrosis (6)
Data (252)
Depression (12)
Dermatology (1)
Diabetes (13)
Diagnostics (225)
Drug discovery (6)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (11143)
Employer resources (1)
Events (2235)
Executive appointments (5)
FDA (576)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (17)
Gene editing (2)
Generative AI (1)
Gene therapy (11)
GLP-1 (32)
Government (82)
Guidances (113)
Healthcare (646)
HIV (2)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (4)
Immuno-oncology (3)
Indications (4)
Infectious disease (52)
Inflammatory bowel disease (3)
Interviews (12)
IPO (1138)
Job creations (98)
Job search strategy (42)
JPM (2)
Kidney cancer (1)
Labor market (2)
Layoffs (4)
Leadership (1)
Legal (124)
Lung cancer (27)
Lymphoma (15)
Machine learning (3)
Management (1)
Manufacturing (13)
MASH (8)
Medical device (616)
Medtech (621)
Mergers & acquisitions (381)
Metabolic disorders (37)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (9)
Neuropsychiatric disorders (6)
Neuroscience (108)
NextGen: Class of 2026 (134)
Non-profit (40)
Obesity (12)
Opinion (7)
Ovarian cancer (3)
Pain (4)
Pancreatic cancer (7)
Parkinson's disease (10)
Partnered (2)
Patents (1)
Patient recruitment (9)
Peanut (2)
People (753)
Pharmacy benefit managers (1)
Phase 1 (509)
Phase 2 (872)
Phase 3 (821)
Pipeline (678)
Postmarket research (66)
Preclinical (144)
Press Release (1)
Prostate cancer (8)
Psychedelics (2)
Radiopharmaceuticals (10)
Rare diseases (23)
Real estate (98)
Recruiting (1)
Regulatory (592)
Reports (2)
Research institute (27)
Resumes & cover letters (14)
RSV (3)
Schizophrenia (5)
Series A (1)
Series B (1)
Service/supplier (1)
Sickle cell disease (1)
Spinal muscular atrophy (3)
Sponsored (2)
Startups (40)
Supply chain (1)
Tariffs (1)
Vaccines (14)
Venture capital (2)
Weight loss (12)
Women's health (2)
Date
Last 7 days (14)
Last 30 days (125)
Last 365 days (1359)
2026 (380)
2025 (1326)
2024 (1600)
2023 (1716)
2022 (1987)
2021 (1913)
2020 (1582)
2019 (1209)
2018 (1142)
2017 (715)
2016 (378)
2015 (2934)
2014 (3652)
2013 (234)
2012 (343)
2011 (414)
2010 (354)
Location
Africa (15)
Alabama (3)
Arizona (10)
Asia (1544)
Australia (150)
California (533)
Canada (123)
China (31)
Colorado (40)
Connecticut (21)
Delaware (27)
Europe (3135)
Florida (70)
Georgia (20)
Idaho (2)
Illinois (44)
India (2)
Indiana (43)
Japan (28)
Kentucky (3)
Louisiana (7)
Maine (1)
Maryland (83)
Massachusetts (354)
Michigan (17)
Minnesota (28)
Missouri (5)
Montana (3)
Nevada (2)
New Hampshire (7)
New Jersey (196)
New York (128)
North Carolina (84)
Northern California (263)
Ohio (17)
Pennsylvania (170)
South America (31)
Southern California (219)
Tennessee (7)
Texas (69)
United States (2024)
Utah (19)
Virginia (9)
Washington D.C. (2)
Washington State (38)
Wisconsin (4)
23,933 Results for "152".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoViricides Presenting at NIBA’s 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
March 11, 2026
·
4 min read
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B
GSK said Thursday it plans to divest its remaining 4.2% stake in the consumer health spinout, its fourth and final round of selling off Haleon shares worth approximately $1.52 billion.
May 17, 2024
·
2 min read
·
Tristan Manalac
Business
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY
Specialty cancer diagnostics company Precipio, Inc., announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to $15.2M in 2023, an increase of 60% year over year.
February 13, 2024
·
3 min read
Press Releases
Whim Syndrome Market Size to Reach USD 15.2 Million by 2035, Impelled by Technological Advancements
February 13, 2025
·
7 min read
Press Releases
Orbia Fluor & Energy Materials Advances Project to Increase Production of Zephex® 152a in UK
December 3, 2024
·
4 min read
Pharm Country
Ocugen Announces Publication of a Comprehensive Review of BBV152 in Frontiers in Immunology
Ocugen, Inc. announced the publication “A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects” appeared in Frontiers in Immunology.
September 14, 2022
·
3 min read
BioMidwest
Assertio Increases Full-Year Net Product Sales Outlook to in Excess of $152 Million
Assertio Holdings, Inc. announced that it is raising its outlook for 2022 full-year net product sales to greater than $152 million, increased from its prior outlook calling for net product sales of greater than $141 million for the full year.
December 5, 2022
·
3 min read
Stomach Cancer Treatment Market Size to Gain USD 15.2 BN by 2030
According to Nova one advisor, the global Stomach Cancer Treatment Market Size accounted for USD 4.83 Billion in 2022 and is estimated to achieve a market size of USD 15.2 Billion by 2030 growing at a CAGR of 14.9% from 2022 to 2030.
November 22, 2022
·
6 min read
Population Health Management Market Size to Surpass US$ 152.2 BN by 2029
The population health management market size is expected to surpass around US$ 152.2 billion by 2029 and growing at a CAGR 20.5% over the forecast period 2021 to 2030.
March 29, 2022
·
5 min read
Dental Bone Grafts And Substitutes Market Size to Surpass USD 1.52 BN by 2030
According to Vision Research Reports, the dental bone grafts and substitutes market was valued at USD 645.2 million in 2021 and it is predicted to surpass around USD 1.52 billion by 2030 with a CAGR of 9.99% from 2022 to 2030.
May 25, 2022
·
7 min read
1 of 2,394
Next
